MorphoSys Competitors

(DDXS) (OTCMKTS:DDXS) and MorphoSys (OTCMKTS:MPSYF) are both health technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability.

Profitability

This table compares (DDXS) and MorphoSys' net margins, return on equity and return on assets.

Valuation & Earnings

This table compares (DDXS) and MorphoSys' revenue, earnings per share (EPS) and valuation.

Analyst Recommendations

This is a summary of current ratings for (DDXS) and MorphoSys, as provided by MarketBeat.com.

MorphoSys (OTCMKTS:MPSYF) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

Profitability

This table compares MorphoSys and (TNGN)'s net margins, return on equity and return on assets.

Earnings & Valuation

This table compares MorphoSys and (TNGN)'s top-line revenue, earnings per share and valuation.

Analyst Ratings

This is a summary of recent recommendations and price targets for MorphoSys and (TNGN), as reported by MarketBeat.

MorphoSys (OTCMKTS:MPSYF) and Abattis Bioceuticals (OTCMKTS:ATTBF) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

Profitability

This table compares MorphoSys and Abattis Bioceuticals' net margins, return on equity and return on assets.

Earnings & Valuation

This table compares MorphoSys and Abattis Bioceuticals' top-line revenue, earnings per share and valuation.

Analyst Ratings

This is a summary of recent recommendations and price targets for MorphoSys and Abattis Bioceuticals, as reported by MarketBeat.

MorphoSys (OTCMKTS:MPSYF) and ADiTx Therapeutics (NASDAQ:ADTX) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

Profitability

This table compares MorphoSys and ADiTx Therapeutics' net margins, return on equity and return on assets.

Earnings & Valuation

This table compares MorphoSys and ADiTx Therapeutics' top-line revenue, earnings per share and valuation.

Analyst Ratings

This is a summary of recent recommendations and price targets for MorphoSys and ADiTx Therapeutics, as reported by MarketBeat.

Summary

ADiTx Therapeutics beats MorphoSys on 2 of the 2 factors compared between the two stocks.

MorphoSys (OTCMKTS:MPSYF) and Algernon Pharmaceuticals (OTCMKTS:AGNPF) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

Analyst Ratings

This is a summary of recent recommendations and price targets for MorphoSys and Algernon Pharmaceuticals, as reported by MarketBeat.

Earnings & Valuation

This table compares MorphoSys and Algernon Pharmaceuticals' top-line revenue, earnings per share and valuation.

Profitability

This table compares MorphoSys and Algernon Pharmaceuticals' net margins, return on equity and return on assets.

Almirall (OTCMKTS:LBTSF) and MorphoSys (OTCMKTS:MPSYF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations and earnings.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Almirall and MorphoSys, as reported by MarketBeat.com.

Valuation & Earnings

This table compares Almirall and MorphoSys' top-line revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Almirall and MorphoSys' net margins, return on equity and return on assets.

Summary

Almirall beats MorphoSys on 2 of the 2 factors compared between the two stocks.